NG CELL
Progressive Multiple Sclerosis (MS)
Key Facts
About NeuroGenesis Bio
NeuroGenesis Bio is a private, clinical-stage biotechnology company based in San Diego, CA, founded in 2007. The company is developing the NG CELL™ platform, an autologous cell therapy designed to deliver sustained levels of therapeutic proteins directly to the central nervous system to repair damage in progressive MS and ALS. With a seasoned leadership team experienced in cell therapy development and neurology, NeuroGenesis is advancing its lead programs through clinical trials. The company operates as a pre-revenue therapeutics developer targeting significant unmet needs in neurodegenerative diseases.
View full company profileAbout NeuroGenesis Bio
NeuroGenesis Bio is a private, clinical-stage biotechnology company based in San Diego, CA, founded in 2007. The company is developing the NG CELL™ platform, an autologous cell therapy designed to deliver sustained levels of therapeutic proteins directly to the central nervous system to repair damage in progressive MS and ALS. With a seasoned leadership team experienced in cell therapy development and neurology, NeuroGenesis is advancing its lead programs through clinical trials. The company operates as a pre-revenue therapeutics developer targeting significant unmet needs in neurodegenerative diseases.
View full company profileOther Progressive Multiple Sclerosis (MS) Drugs
| Drug | Company | Phase |
|---|---|---|
| Masitinib | AB Science | Phase 3 |
| NurOwn® Platform | BrainStorm Cell Therapeutics | Phase 2 |